Adjusted EBITDA Growth and Margin Expansion
Total company adjusted EBITDA increased ~10% year-over-year to $398 million, with adjusted EBITDA margin expanding 500 basis points to 30.8%.
Adjusted Gross Profit and EPS Improvement
Adjusted gross profit rose 6.8% to $556 million, gross margin expanded by 610 basis points, and diluted adjusted EPS improved 30% to $4.55.
Record Free Cash Flow and Share Buybacks
Generated $274 million of free cash flow (highest in 5 years), a $220 million increase vs. 2024; used cash to repurchase ~$56 million (≈1 million shares) and resume buybacks with ~ $300 million remaining authorization.
Debt Reduction and Leverage Improvement
Reduced net leverage from 3.5x to 2.6x (nearly a full turn improvement), exceeding the prior target of below 2.8x and positioning to reach 2.0–2.5x in 2026.
Performance Materials Strong Margin Resilience
Performance Materials sales of $607 million were flat year-over-year despite lower auto production; segment EBITDA margin remained robust at 53.8% (expected to stay north of 50%).
Performance Chemicals Repositioning Benefits
Combined Performance Chemicals segment EBITDA increased by $45 million year-over-year; continuing operations EBITDA rose $7 million (12%); combined segment EBITDA margin expanded to 13.5% from 4% a year ago due to repositioning, lower raw material costs and improved logistics.
Operational Discipline in APT
Advanced Polymer Technologies (APT) achieved a strong EBITDA margin of 20% despite sales declining 15% and EBITDA falling 18%, supported by operating efficiency and favorable FX.
Completed Strategic Divestiture
Completed sale of North Charleston CTO refinery and majority of Industrial Specialties on Jan 1, 2026, which management says reduced portfolio volatility and strengthened profitability/cash flow.
2026 Financial Guidance and Capital Allocation
Guidance for 2026: adjusted EPS $4.08–$5.20, sales $1.1–$1.2 billion, adjusted EBITDA $380–$400 million, capex $40–$60 million, and expected free cash flow $225–$250 million (guidance excludes ~ $95 million pre-tax litigation payment). Company plans $300 million of share repurchases through 2027.
Strong Total Shareholder Return in 2025
Delivered 45% total shareholder return in 2025, highest among specialty chemicals peers and top quartile in Russell 2000 materials companies.